Radiographers Read Mammograms for UK Double Reading Program
WEDNESDAY, Sept. 28, 2022 (HealthDay News) — Trained radiographers perform as well as radiologists when participating in the double reading of screening mammograms, according to a study published online Sept. 13 in Radiology.Yan Chen, Ph.D., from the…
Learn MoreKatie Couric Announces Breast Cancer Diagnosis
WEDNESDAY, Sept. 28, 2022 (HealthDay News) — Former TV newswoman and TODAY show anchor Katie Couric has breast cancer. Couric shared that information Wednesday on Instagram, while also releasing an essay about the experience on her media website.”Eve…
Learn MoreNew Alzheimer’s Drug Shows Promise in Phase 3 Clinical Trial
WEDNESDAY, Sept. 28, 2022 (HealthDay) — Japanese drugmaker Eisai on Wednesday said its experimental drug lecanemab helped slow thinking declines among people in the early stages of Alzheimer’s disease. The findings from a phase 3 clinical trial have …
Learn MoreLos presos de EE. UU. tienen más probabilidades de morir de cáncer
LUNES, 26 de septiembre de 2022 (HealthDay News) — Otro motivo para no ir a la cárcel: una investigación reciente muestra que el riesgo de morir de cáncer es mucho más alto entre los que están tras las rejas o que han quedado libres hace poco.En las …
Learn MoreUn estudio apunta a los trabajos con los mayores riesgos de ELA
LUNES, 26 de septiembre de 2022 (HealthDay News) — Las personas que trabajan en fabricación, soldadura y operaciones químicas y se exponen a compuestos peligrosos podrían enfrentarse a un riesgo más alto de desarrollar esclerosis lateral amiotrófica …
Learn MoreAdenoma Detection Rate Tied to CRC Risk After Positive FIT
TUESDAY, Sept. 27, 2022 (HealthDay News) — The adenoma detection rate (ADR) of endoscopists is associated with the risk for interval postcolonoscopy colorectal cancers (PCCRCs) after a positive fecal immunochemical testing (FIT) result, according to …
Learn MoreMetachronous Pathology Assessed in Young-Onset CRC Survivors
TUESDAY, Sept. 27, 2022 (HealthDay News) — The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published online …
Learn MoreTriplet Therapy Ups Progression-Free Survival in Advanced Kidney Cancer
MONDAY, Sept. 26, 2022 (HealthDay News) — Triplet therapy of cabozantinib + nivolumab + ipilimumab significantly improves progression-free survival (PFS) compared with placebo + nivolumab + ipilimumab for patients with previously untreated advanced r…
Learn MoreOdds of Fair/Poor Health Up for Low-Income Cancer Survivors
MONDAY, Sept. 26, 2022 (HealthDay News) — Low-income cancer survivors have increased odds of fair/poor health, and reduced odds of having health insurance coverage, according to a study published online Sept. 6 in JCO Oncology Practice.Steven S. Coug…
Learn MoreHay señales de que un fármaco experimental podría frenar una forma de ELA
VIERNES, 23 de septiembre de 2022 (HealthDay News) — Las personas con una rara forma genética de la ELA quizá se beneficien del uso extendido de un medicamento bajo investigación, muestra un estudio reciente.El fármaco, tofersen, benefició a los paci…
Learn More